🇺🇸 FDA
Patent

US 10905736

Ezetimibe-associated ApoA-I mimetic peptides showing enhanced synergism

granted A61KA61K38/04A61K38/1709

Quick answer

US patent 10905736 (Ezetimibe-associated ApoA-I mimetic peptides showing enhanced synergism) held by The Regents of the University of California expires Mon Jan 28 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Feb 02 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 28 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
26
CPC classes
A61K, A61K38/04, A61K38/1709, A61K9/0053, A61K9/141